910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)Ezra E.W. Cohen, N. Lee, Margarida Teixeira et al.|Annals of Oncology|2020Cited by 42